| Gujarat Themis Biosyn Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506879 |
NSE Symbol : - |
P/E(TTM) : 69.63 |
|
ISIN Demat : INE942C01045 |
Div & Yield% : 0.19 |
EPS(TTM) : 5.02 |
|
Book Value(₹) : 18.48 |
Market Cap(₹Cr) : 3,808.88 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 38.83 | 42.01 | 38.57 | 39.65 | 49.59 | 27.59 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 38.83 | 42.01 | 38.57 | 39.65 | 49.59 | 27.59 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.52 | 1.02 | 1.27 | 1.00 | 1.07 | 1.96 |
| Total Income | 39.35 | 43.03 | 39.84 | 40.65 | 50.66 | 29.55 |
| Total Expenditure | 20.28 | 21.08 | 21.09 | 22.83 | 26.08 | 13.22 |
| PBIDT | 19.07 | 21.95 | 18.75 | 17.82 | 24.58 | 16.33 |
| Interest | 0.07 | 0.07 | 0.08 | 0.05 | 0.03 | 0.02 |
| PBDT | 19.01 | 21.87 | 18.67 | 17.77 | 24.56 | 16.30 |
| Depreciation | 1.15 | 0.92 | 0.98 | 0.88 | 0.75 | 0.77 |
| Tax | 4.57 | 4.97 | 4.61 | 4.23 | 5.99 | 3.83 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.05 | 0.10 | 0.07 | 0.11 | 0.10 | 0.01 |
| Reported Profit After Tax | 13.24 | 15.89 | 13.01 | 12.54 | 17.72 | 11.69 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 13.24 | 15.89 | 13.01 | 12.54 | 17.72 | 11.69 |
| EPS (Unit Curr.) | 1.82 | 2.19 | 1.79 | 8.63 | 12.20 | 8.05 |
| EPS (Adj) (Unit Curr.) | 1.21 | 1.46 | 1.19 | 1.15 | 1.63 | 1.07 |
| Calculated EPS (Unit Curr.) | 1.82 | 2.19 | 1.79 | 8.63 | 12.20 | 8.05 |
| Calculated EPS (Adj) (Unit Curr.) | 1.21 | 1.46 | 1.19 | 1.15 | 1.63 | 1.07 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.29 | 8.75 | 7.17 | 34.53 | 48.79 | 32.19 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.86 | 5.83 | 4.78 | 4.60 | 6.51 | 4.29 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 75.00 | 75.00 | 0.00 | 0.00 | 0.00 |
| Equity | 7.26 | 7.26 | 7.26 | 7.26 | 7.26 | 7.26 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 49.11 | 52.25 | 48.61 | 44.94 | 49.57 | 59.19 |
| PBDTM(%) | 48.96 | 52.06 | 48.41 | 44.82 | 49.53 | 59.08 |
| PATM(%) | 34.10 | 37.82 | 33.73 | 31.63 | 35.73 | 42.37 |